Half-year report · HY
6925.TEDINET S100X3XJ
Period2025-04-01 → 2025-09-30
Filed2025-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥81.4bn | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥177.6bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥85.6bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | ¥4.0bn | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | ¥4.3bn | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥5.0bn | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥12.5bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥5.4bn | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥2.2bn | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥4.8bn | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥240m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥6.8bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.3bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥241m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | ¥2.3bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥301.5bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥297.3bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥316.8bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥112.9bn | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥96.8bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥188.7bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥200.5bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥217.7bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥69.9bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥61.3bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥67.0bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥60.0bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥55.4bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥62.5bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥8.3bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥20.4bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥7.3bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥2.7bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥2.7bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥6.8bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥779m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥25.0bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥5.7bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥2.77 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥70.27 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥22.95 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 62.6% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 67.4% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 68.7% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 61
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2025-04-01 → 2025-09-30 | ¥666m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2025-04-01 → 2025-09-30 | ¥659m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥7m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-04-01 → 2025-09-30 | −¥45m |
| Reconciling Itemsreconciling | revenue | 2025-04-01 → 2025-09-30 | −¥17m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-04-01 → 2025-09-30 | −¥17m |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2025-09-30 | −¥48m |
| Industrial Processesreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥34.4bn |
| Industrial Processesreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥34.4bn |
| Industrial Processesreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥0 |
| Industrial Processesreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥2.0bn |
| Life Sciencesreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥3.3bn |
| Life Sciencesreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥3.3bn |
| Life Sciencesreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥2m |
| Life Sciencesreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥169m |
| Photonics Solutionsreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥5.0bn |
| Photonics Solutionsreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥5.0bn |
| Photonics Solutionsreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥0 |
| Photonics Solutionsreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥85m |
| Visual Imagingreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥38.1bn |
| Visual Imagingreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥38.1bn |
| Visual Imagingreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥6m |
| Visual Imagingreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥1.8bn |
| —segment total | revenue | 2025-04-01 → 2025-09-30 | ¥80.8bn |
| —segment total | revenue external | 2025-04-01 → 2025-09-30 | ¥80.8bn |
| —segment total | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥9m |
| —segment total | segment profit | 2025-04-01 → 2025-09-30 | ¥4.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-04-01 → 2025-09-30 | ¥81.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-04-01 → 2025-09-30 | ¥81.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥17m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-04-01 → 2025-09-30 | ¥4.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-04-01 → 2024-09-30 | ¥632m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-04-01 → 2024-09-30 | ¥625m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥6m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2024-09-30 | ¥33m |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2024-09-30 | −¥13m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2024-09-30 | −¥13m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥48m |
| Industrial Processesreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥37.6bn |
| Industrial Processesreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥37.6bn |
| Industrial Processesreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥2m |
| Industrial Processesreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥5.2bn |
| Life Sciencesreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥3.1bn |
| Life Sciencesreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥3.0bn |
| Life Sciencesreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥1m |
| Life Sciencesreportable segment | segment profit | 2024-04-01 → 2024-09-30 | −¥554m |
| Photonics Solutionsreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥5.1bn |
| Photonics Solutionsreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥5.1bn |
| Photonics Solutionsreportable segment | segment profit | 2024-04-01 → 2024-09-30 | −¥281m |
| Visual Imagingreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥39.3bn |
| Visual Imagingreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥39.3bn |
| Visual Imagingreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥2m |
| Visual Imagingreportable segment | segment profit | 2024-04-01 → 2024-09-30 | −¥120m |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥85.0bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥85.0bn |
| —segment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥6m |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥4.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥85.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥85.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥13m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥4.3bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 603
| Item | Context | Value | Unit |
|---|---|---|---|
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E01929-000PhotonicsSolutionsReportableSegmentsMember | -281000000 | JPY |
| Operating income | Prior1InterimDuration_ReportableSegmentsMember | 4285000000 | JPY |
| Operating income | Prior1InterimDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 33000000 | JPY |
| Operating income | Prior1InterimDuration_TotalOfReportableSegmentsAndOthersMember | 4318000000 | JPY |
| Operating income | Prior1InterimDuration_ReconcilingItemsMember | -48000000 | JPY |
| Operating income | Prior1InterimDuration | 4270000000 | JPY |
| Revenues from external customers | InterimDuration_jpcrp040300-ssr_E01929-000IndustrialProcessesReportableSegmentsMember | 34433000000 | JPY |
| Revenues from external customers | InterimDuration_jpcrp040300-ssr_E01929-000VisualImagingReportableSegmentsMember | 38071000000 | JPY |
| Revenues from external customers | InterimDuration_jpcrp040300-ssr_E01929-000LifeSciencesReportableSegmentsMember | 3285000000 | JPY |
| Revenues from external customers | InterimDuration_jpcrp040300-ssr_E01929-000PhotonicsSolutionsReportableSegmentsMember | 4975000000 | JPY |
| Revenues from external customers | InterimDuration_ReportableSegmentsMember | 80765000000 | JPY |
| Revenues from external customers | InterimDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 659000000 | JPY |
| Revenues from external customers | InterimDuration_TotalOfReportableSegmentsAndOthersMember | 81425000000 | JPY |
| Revenues from external customers | InterimDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | InterimDuration | 81425000000 | JPY |
| Transactions with other segments | InterimDuration_jpcrp040300-ssr_E01929-000IndustrialProcessesReportableSegmentsMember | 0 | JPY |
| Transactions with other segments | InterimDuration_jpcrp040300-ssr_E01929-000VisualImagingReportableSegmentsMember | 6000000 | JPY |
| Transactions with other segments | InterimDuration_jpcrp040300-ssr_E01929-000LifeSciencesReportableSegmentsMember | 2000000 | JPY |
| Transactions with other segments | InterimDuration_jpcrp040300-ssr_E01929-000PhotonicsSolutionsReportableSegmentsMember | 0 | JPY |
| Transactions with other segments | InterimDuration_ReportableSegmentsMember | 9000000 | JPY |
| Transactions with other segments | InterimDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 7000000 | JPY |
| Transactions with other segments | InterimDuration_TotalOfReportableSegmentsAndOthersMember | 17000000 | JPY |
| Transactions with other segments | InterimDuration_ReconcilingItemsMember | -17000000 | JPY |
| Transactions with other segments | InterimDuration | － | JPY |
| Net sales | InterimDuration_jpcrp040300-ssr_E01929-000IndustrialProcessesReportableSegmentsMember | 34434000000 | JPY |
| Net sales | InterimDuration_jpcrp040300-ssr_E01929-000VisualImagingReportableSegmentsMember | 38077000000 | JPY |
| Net sales | InterimDuration_jpcrp040300-ssr_E01929-000LifeSciencesReportableSegmentsMember | 3288000000 | JPY |
| Net sales | InterimDuration_jpcrp040300-ssr_E01929-000PhotonicsSolutionsReportableSegmentsMember | 4976000000 | JPY |
| Net sales | InterimDuration_ReportableSegmentsMember | 80775000000 | JPY |
| Net sales | InterimDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 666000000 | JPY |
| Net sales | InterimDuration_TotalOfReportableSegmentsAndOthersMember | 81442000000 | JPY |
| Net sales | InterimDuration_ReconcilingItemsMember | -17000000 | JPY |
| Net sales | InterimDuration | 81425000000 | JPY |
| Operating income | InterimDuration_jpcrp040300-ssr_E01929-000IndustrialProcessesReportableSegmentsMember | 2048000000 | JPY |
| Operating income | InterimDuration_jpcrp040300-ssr_E01929-000VisualImagingReportableSegmentsMember | 1805000000 | JPY |
| Operating income | InterimDuration_jpcrp040300-ssr_E01929-000LifeSciencesReportableSegmentsMember | 169000000 | JPY |
| Operating income | InterimDuration_jpcrp040300-ssr_E01929-000PhotonicsSolutionsReportableSegmentsMember | 85000000 | JPY |
| Operating income | InterimDuration_ReportableSegmentsMember | 4108000000 | JPY |
| Operating income | InterimDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | -45000000 | JPY |
| Operating income | InterimDuration_TotalOfReportableSegmentsAndOthersMember | 4063000000 | JPY |
| Operating income | InterimDuration_ReconcilingItemsMember | -48000000 | JPY |
| Operating income | InterimDuration | 4014000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の５第１項の表の第１号 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2025-11-13 | |
| Semi annual accounting period cover page | FilingDateInstant | Original text (Japanese)第63期中（自 2025年４月１日 至 2025年９月30日） | |
| Company name cover page | FilingDateInstant | Original text (Japanese)ウシオ電機株式会社 | |
| Company name in english cover page | FilingDateInstant | USHIO INC. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 朝日 崇文 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |